disease of intestine,unspecified. disease of intestine,unspecified
Conditions
Interventions
Intervention 1: Group A: Fentanyl 0.7 microgram/kg and bolus dose of propofol 1 mg/kg. Intervention 2: Group B: propofol 1 mg/kg intravenously and bolus dose of Ketamine 0.5 mg/kg.
Sponsors
Babol University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 55 Years
Inclusion criteria
Inclusion criteria: patients scheduled for comlete elective colonoscopy 18-55 years old ASA class I-II
Exclusion criteria
Exclusion criteria: History of large bowel surgery Pregnancy Patients with psychiatric and emotional disorder History of addiction History of allergic reaction History of pulmonary and metabolic disorders
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain. Timepoint: Before of discharge. Method of measurement: Visual Analogues Scale. | — |
Secondary
| Measure | Time frame |
|---|---|
| Drug adverse effects. Timepoint: Before and after colonoscopy. Method of measurement: Before and after colonoscopy.;Colonoscopist satisfaction. Timepoint: After colonoscopy. Method of measurement: Numerical rating scale for colonoscopist satisfaction.;Blood pressure. Timepoint: Every 5 minutes. Method of measurement: Noninvasive cuff measurrment.;Heart rate. Timepoint: Every 5 minutes. Method of measurement: Pulse counting. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr Mohammad Esmaeili
Babol University of Medical Sciences
Outcome results
None listed